Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.25B |
| 2 |
CSX Corp
CSX
|
+$1.25B |
| 3 |
Verizon
VZ
|
+$935M |
| 4 |
Micron Technology
MU
|
+$925M |
| 5 |
Harley-Davidson
HOG
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$1.51B |
| 2 |
Philip Morris
PM
|
+$1.36B |
| 3 |
American International
AIG
|
+$1.25B |
| 4 |
McKesson
MCK
|
+$1.11B |
| 5 |
Caterpillar
CAT
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.27% |
| 2 | Technology | 16.26% |
| 3 | Consumer Discretionary | 11.9% |
| 4 | Financials | 11.32% |
| 5 | Communication Services | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
American Tower
AMT
$79.4B
| $62.6M | 0.02% |
473,264
-1,005,230
| -68% | -$129M |
|
327
Ferrari
RACE
$71.6B
| $61.8M | 0.02% |
720,308
-437,325
| -38% | -$35.8M |
|
328
Alexandria Real Estate Equities
ARE
$8.27B
| $59.1M | 0.02% |
490,491
+491
| +0.1% | +$57.1K |
|
|
PPL
329
PPL Corp
PPL
$26.7B
| $58.8M | 0.02% |
1,522,150
| – | – |
|
330
Sherwin-Williams
SHW
$87.4B
| $58.3M | 0.02% |
498,000
| – | – |
|
331
Artivion
AORT
$1.4B
| $57M | 0.02% |
2,857,449
-263,837
| -8% | -$4.73M |
|
|
WBT
332
DELISTED
Welbilt, Inc.
WBT
| $56.5M | 0.02% |
3,000,000
+1,431,642
| +91% | +$28M |
|
333
Royal Caribbean
RCL
$82.4B
| $54.6M | 0.02% |
500,000
| – | – |
|
334
Silicon Laboratories
SLAB
$7.22B
| $54.4M | 0.02% |
796,600
-42,000
| -5% | -$3.04M |
|
|
DNR
335
DELISTED
Denbury Resources, Inc.
DNR
| $51.9M | 0.02% |
33,933,868
-1,144,567
| -3% | -$2.14M |
|
|
CRZO
336
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $51.4M | 0.02% |
2,950,270
-2,587,196
| -47% | -$60.1M |
|
337
BP
BP
$111B
| $50.8M | 0.02% |
1,652,981
-2
| -0% | -$62 |
|
|
B
338
Barrick Mining
B
$67.9B
| $50.5M | 0.02% |
3,175,587
+909,926
| +40% | +$15.6M |
|
339
Pfizer
PFE
$150B
| $50.4M | 0.02% |
1,581,000
| – | – |
|
340
Carlisle Companies
CSL
$15.2B
| $49.6M | 0.02% |
519,534
+534
| +0.1% | +$54K |
|
341
Cognex
CGNX
$10.2B
| $49.3M | 0.02% |
1,162,404
-40,000
| -3% | -$1.78M |
|
|
LGF.A
342
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $49.3M | 0.02% |
1,746,791
-530,970
| -23% | -$14M |
|
343
Edwards Lifesciences
EW
$53.6B
| $47.3M | 0.01% |
1,201,161
-748,845
| -38% | -$27.3M |
|
344
Penske Automotive Group
PAG
$14.3B
| $45.3M | 0.01% |
1,030,875
-473,000
| -31% | -$20.8M |
|
|
CY
345
DELISTED
Cypress Semiconductor
CY
| $45M | 0.01% |
3,300,000
| – | – |
|
346
CONMED
CNMD
$1.48B
| $44.9M | 0.01% |
881,000
-202,000
| -19% | -$9.99M |
|
347
Old Republic International
ORI
$10.3B
| $43M | 0.01% |
2,200,800
| – | – |
|
348
MACOM Technology Solutions
MTSI
$23.7B
| $42.4M | 0.01% |
+759,692
| New | +$41M |
|
349
Curtiss-Wright
CW
$26.7B
| $42.3M | 0.01% |
+461,207
| New | +$41.6M |
|
350
Evertec
EVTC
$1.82B
| $42.2M | 0.01% |
2,438,000
+594,000
| +32% | +$9.72M |
|
Similar funds
Capital Research Global Investors's Q2 2017 Portfolio in Review
As of Q2 2017, Capital Research Global Investors held 454 positions worth $319B, up 0.77% from $317B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Capital Research Global Investors's Q2 2017 filing shows 29 new, 155 increased, 158 reduced and 23 closed positions. Its largest new stake was L3Harris: 2,791,603 shares worth $305M. The largest sale was Union Pacific, an estimated $1.51B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Capital Research Global Investors's largest Q2 2017 buy was L3Harris: 2,791,603 shares worth $305M.
- Capital Research Global Investors added most to Microsoft in Q2 2017, an estimated $3.25B increase.
- Capital Research Global Investors's biggest Q2 2017 reduction was Union Pacific, cutting an estimated $1.51B.
- Capital Research Global Investors fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $525M.
- Capital Research Global Investors's ten largest holdings make up 24% of its $319B portfolio in Q2 2017.
- Capital Research Global Investors opened 29 new positions and closed 23 in Q2 2017.
- Capital Research Global Investors's portfolio value rose 0.77% quarter-over-quarter to $319B.
Based on Capital Research Global Investors's 13F filing for Q2 2017, filed 14 Aug 2017.